Next‐generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer New

Abstract

Objectives

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To evaluate the effectiveness and safety of matched targeted therapies in people with relapsed or metastatic cancer in phase I, II and III trials.

Author(s)

Farasat Kazmi, Nipun Shrestha, Stephen Booth, David Dodwell, Francesca Aroldi, Thomas Foord, Brian D Nicholson, Philip Heesen, Simon Lord, Kheng-Wei Yeoh, Sarah Blagden

Reviewer's Conclusions

Get full text at The Cochrane Library

Next‐generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer New is a sample topic from the Cochrane Abstracts.

To view other topics, please or .

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. .